In Brief: FDA's National Mammography Quality Assurance Advisory Committee
This article was originally published in The Gray Sheet
FDA's National Mammography Quality Assurance Advisory Committee: Meeting July 10, 11 and 12 at the DoubleTree Hotel in Rockville, Maryland. On July 10, "the committee will hear updates on approvals for alternative standards under the Mammography Quality Standards Act (MQSA) of 1992," according to the June 24 Federal Register. On July 10 and 11 the committee will discuss digital mammography under the MQSA. On July 12 the committee will discuss the issue of states as certifying bodies as well as the ongoing work of subcommittee. For more information, contact FDA's Charles Showalter, 301/594-3332...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.